经济观察网昊海生物科技近期最受关注的事件是股东减持计划。2026年2月12日，公司公告股东楼国梁 因自身资金需要，计划在公告披露后3个交易日起的3个月内，通过集中竞价和大宗交易方式减持不超过 100万股股份，占公司总股本比例不超过0.4337%。该减持计划可能对短期市场情绪构成压力，但符合 股东此前的上市承诺。 股票近期走势 股价方面，昊海生科A股(688366.SH)近期表现偏弱。截至2026年2月13日收盘，股价报45.91元，当日下 跌1.21%，近5日累计下跌2.28%；同期港股昊海生物科技(06826.HK)收于26.72港元，当日上涨2.06%， 但近5日振幅达4.55%。资金流向显示，2月13日A股主力资金净流出约100万元，反映短期资金面承压。 技术面上，A股股价已跌破5日均线(46.22元)，MACD指标出现死叉信号；港股则位于布林带中轨 (26.034港元)附近，KDJ指标中J线升至78.96，显示短期超买。 财报分析 公司2025年第三季度业绩出现下滑。根据三季报数据，单季度营收同比下降11.29%至5.95亿元，归母净 利润同比下降11.39%至9358.21万元；前三季度累计营收同比 ...

以上内容基于公开资料整理，不构成投资建议。 昊海生科 昊海生物科技 分时图 日K线 周K线 月K线 46.13 -0.34 -0.73% 0.77% 0.52% 0.26% 0.00% 0.26% 0.52% 0.77% 46.11 46.23 46.35 46.47 46.59 46.71 46.83 09:30 10:30 11:30/13:00 14:00 15:00 15:30 0 8152 2万 2万 经济观察网2026年2月12日，昊海生科发布公告称，股东楼国梁因自身资金需要，计划通过集中竞价和 大宗交易方式减持不超过100万股公司股份，占公司总股本的比例不超过0.4337%。截至公告日，楼国 梁持有公司股份约712万股，持股比例为3.0882%。该减持计划自公告披露后3个交易日起的3个月内实 施，可能对短期市场情绪构成压力。 股票近期走势 受股东减持公告影响，昊海生科股价近期表现偏弱。截至2026年2月13日开盘，股价报46.47元，近5日 累计下跌1.09%。2月12日单日下跌0.81%，成交额约1978.85万元，主力资金净流出6.53万元，显示短期 资金面承压。同期，医药生物板块整体微跌0 ...

Group 1 - Major shareholder Han Yuanfu of Dayuan Pump Industry plans to reduce his stake by up to 3%, totaling no more than 5.595 million shares [1] - Hainan Highway, a shareholder of Haikou Group, intends to increase its stake in the company by no less than 40 million yuan and no more than 50 million yuan [2] - China Communications Construction Company signed new contracts worth 1.883672 trillion yuan in 2025, a year-on-year increase of 0.13% [3] Group 2 - The controlling shareholder of Quzhou Development proposed to repurchase shares worth between 100 million and 200 million yuan [4] - Shareholder Huang Song of Huibo Pu plans to reduce his stake by up to 1%, totaling no more than 1.3372 million shares [5] - The board secretary of Fusenmei has had his detention lifted and is now under investigation, allowing him to resume his duties [6] Group 3 - YN Holdings clarified that its investment target does not belong to the sectors of computing chip manufacturing, computing leasing, or cloud services [7] - Shareholder Euro Star Diamond plans to reduce its stake in Laishen Tongling by up to 3%, totaling no more than 1.029 million shares [8] - Shareholder Zhu Guangkui of Demar Technology plans to reduce his stake by up to 3%, totaling no more than 791.24 million shares [10] Group 4 - Newnow's subsidiary received approval for clinical trials of drug SYS6023 for breast cancer treatment [11] - Ruipubio plans to invest 295 million yuan to establish a merger and acquisition industry fund focusing on animal health and biomedicine [12] - Shareholder Ningbo Hutong plans to reduce its stake in Huitong Energy by up to 1%, totaling no more than 206.28 million shares [13] Group 5 - Chengda Bio's high-dose influenza virus vaccine has received approval for clinical trials [14] - Kang En Bei's subsidiaries participated in the national centralized procurement process, with selected drugs expected to generate 385 million yuan in sales in 2024 [15] - Weitang Industrial signed a strategic cooperation framework agreement with Amphenol to enhance product development and market collaboration [16] Group 6 - Terui De is the first candidate for a 137 million yuan EPC general contracting project [17] - Chen Zhan Optoelectronics plans to invest 650 million yuan to establish an overseas smart manufacturing base [19] - Zhang Yi Technology's AI short drama business revenue is expected to account for no more than 1% of total revenue in 2025 [20] Group 7 - Jiangshan Co. plans to reduce its stake by up to 3%, totaling no more than 4.3308 million shares [21] - Xie Chuang Data plans to procure servers from multiple suppliers, with a total expected expenditure of no more than 11 billion yuan [22] - Huaming Equipment is planning to issue H-shares and list on the Hong Kong Stock Exchange [23] Group 8 - Wenzhou Hongfeng plans to raise no more than 450 million yuan through a private placement for expansion projects [24] - Yingkerui plans to raise no more than 379 million yuan for various projects including smart power supply systems [25] - Jingrui Electric Materials plans to invest 600 million yuan to build a key materials base for the integrated circuit manufacturing industry [26] Group 9 - Beijing Bank's chairman resigned due to age [27] - Youkeshu's actual controller plans to increase his stake by no less than 50 million yuan and no more than 100 million yuan [28] - Hanbo High-tech's subsidiary plans to acquire assets to enter the wet electronic chemicals industry [29] Group 10 - Jia Mei Packaging clarified that its capital operations related to Magic Atom will be independent of the listed company [30] - International Composite Materials confirmed that electronic-grade glass fiber is a key raw material for PCBs [31] - Zhongyin Fashion plans to procure hardware simulation accelerators for 9.385 million USD [32] Group 11 - Haohai Biotechnology's shareholder plans to reduce his stake by up to 0.4337% [33] - United Optoelectronics plans to sign a framework contract with Lingzhi Cloud Creation for robot assembly services [34] - Qianfang Technology's major shareholder plans to reduce its stake by up to 1.5%, totaling no more than 2.36507 million shares [35] Group 12 - Xiamen Airport plans to acquire 100% of Zhaoxiang Technology for 1.193 billion yuan [36] - Tuoshan Heavy Industry plans to acquire 51% of Xin Kaiyuan for 219 million yuan [38] - Shenkai Co. plans to repurchase shares worth between 40 million and 80 million yuan [39] Group 13 - Hushun Co. plans to invest 3.3 billion yuan in a high-end PCB production project [40] - Zhengzhou Bank appointed Wang Sentao as vice president, pending regulatory approval [41]

昊海生科(688366.SH)发布公告，楼国梁因自身资金需要，计划自公告披露之日起3个交易日后3个月 内，通过集中竞价和大宗交易方式合计减持不超过100万股的公司股份，占公司总股本的比例不超过 0.4337%。 ...

智通财经APP讯，昊海生科(688366.SH)发布公告，楼国梁因自身资金需要，计划自公告披露之日起3个 交易日后3个月内，通过集中竞价和大宗交易方式合计减持不超过100万股的公司股份，占公司总股本的 比例不超过0.4337%。 ...

Summary of Key Points Core Viewpoint - Multiple shareholders across various companies are planning to reduce their stakes, indicating potential shifts in ownership and investor sentiment in the market [1]. Shareholder Reductions - **Qianfang Technology**: Hangzhou Haoyue plans to reduce its stake by up to 1.5% [1] - **Caicai Co., Ltd.**: Mingpai Industrial intends to reduce its stake by no more than 3% [1] - **Jingwei Co., Ltd.**: Directors and senior management plan to reduce their holdings by a total of up to 1.53% [1] - **Huitong Energy**: Shareholder Ningbo Hu plans to reduce its holdings by up to 2.0628 million shares [1] - **Huakang Clean**: The actual controller and its concerted actors plan to reduce their stake by no more than 3% [1] - **Dema Technology**: Shareholder Zhu Guangkui intends to reduce his stake by no more than 3% [1] - **Laisentongling**: Oulu Star Diamond plans to reduce its stake by up to 3% [1] - **Huibo Technology**: Huang Song plans to reduce his stake by no more than 1% [1] - **Haizheng Materials**: Sinopec Capital plans to reduce its stake by no more than 1% [1] - **Wuhai Biotechnology**: Lou Guoliang plans to reduce his holdings by a total of up to 1 million shares [1] - **Bofei Electric**: Shareholders Haining Yunge and Haining Jucheng plan to reduce a total of 2.3213 million shares [1] - **Dayuan Pump Industry**: Shareholder Han Yuanfu plans to reduce his stake by up to 5.595 million shares [1] - **Nanwei Software**: Shareholder Qizhong Shiyuan has already reduced his holdings by 4.934 million shares [1] - **Haige Communication**: Shareholder Yang Haizhou plans to reduce his stake by up to 4 million shares [1] - **Fuda Alloy**: Controlling shareholder Wang Dawu plans to reduce his stake by no more than 3% [1]

（文章来源：证券日报） 证券日报网讯 2月12日，昊海生科发布公告称，楼国梁拟于2026年2月26日至5月25日通过集中竞价及大 宗交易减持不超过1000000股，占公司总股本230561595股的比例不超过0.4337%，减持价格依市场确 定。 ...

Summary of Key Points Core Viewpoint - Haohai Biological Technology (688366.SH) announced that Mr. Lou Guoliang plans to reduce his holdings in the company due to personal financial needs, with a maximum reduction of 1 million shares, accounting for no more than 0.4337% of the total share capital [1] Group 1 - Mr. Lou Guoliang intends to reduce his holdings within three months from the announcement date [1] - The reduction will be executed through both centralized bidding and block trading methods, with a maximum of 1 million shares to be sold through each method [1] - The selling price will be determined based on the secondary market price [1]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ | 1 | 衢州发展 | 控股股东提议以1亿元至2亿元回购公司股份 | | --- | --- | --- | | 2 | 海汽集团 | 第二大股东海南高速拟增持公司股份 | | 3 | 有棵树 | 实际控制人、董事王维计划增持公司股份 | | | | 2.12上市公司盘后减持情况 | | 1 | 千方科技 | 股东杭州灏月拟减持不超1.5%股份 | | 2 | 福达合金 | 控股股东王达武拟减持不超3%股份 | | 3 | 大族激光 | 控股股东大族控股拟减持不超0.9672%股份 | | ব | 大元泉业 | 股东韩元富拟减持不超3%股份 | | 5 | 华康洁净 | 控股股东、实际控制人及其一致行动人拟合计减持股份 | | 6 | 经纬股份 | 董事兼副总经理钟宜国、徐世峰拟合计减持不超1.53%股份 | | 7 | 海IF生材 | 股东中石化资本拟减持不超1%股份 | | 8 | 重博音 | 股东黄松拟减持不超1%股份 | | 0 | 苹绅通灵 | 股东欧陆之星钻石拟合计减持不超3.00%股份 | | 10 | 泰陵微 | 第三 ...

昊海生物科技(06826)公布，楼国梁先生因自身资金需要，计划自本公告披露之日起3个交易日后3个月 内，通过集中竞价和大宗交易方式合计减持不超过100万股的公司股份，占公司总股本的比例不超过 0.4337%，其中，通过集中竞价方式减持不超过100万股，通过大宗交易方式减持不超过100万股。减持 价格将根据二级市场价格确定。 ...